Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Pharma Intermediate. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Efficient Rh-catalyzed oxidative cyclization for fused heterocycles. Reduces steps and cost for high-purity pharmaceutical intermediates manufacturing.
Patent CN114524701B reveals a novel chiral phosphoric acid catalyzed route for N-N axis chiral pyrroles, offering high enantioselectivity and cytotoxic potential for drug discovery.
Patent CN113121462B reveals a metal-free synthesis of 5-trifluoromethyl-1,2,3-triazoles. Discover cost-effective, scalable manufacturing for high-purity pharmaceutical intermediates.
Patent CN115093355B reveals a novel transesterification method for pyrrole esters. This report analyzes cost reduction in fine chemical manufacturing and supply chain reliability for pharmaceutical intermediates.
Novel CO2 fixation method for benzoxazin-2-one derivatives. Green chemistry, high yield, scalable pharmaceutical intermediate manufacturing process for global supply.
Patent CN110862368A reveals a metal-free photocatalytic route for benzocoumarins using DDQ/TBN and oxygen, offering significant cost and purity advantages for pharmaceutical intermediates.
Novel photocatalytic method for cyanosulfonyl fluoride compounds offers efficient synthesis and supply chain advantages for pharmaceutical intermediates manufacturing globally.
Patent CN114920707B reveals a novel iodine-promoted cyclization using DMF as a carbon source, offering significant cost reduction in API manufacturing and simplified supply chains.
Discover a novel synthesis route for 7-methoxy-1-naphthylacetonitrile avoiding expensive DDQ and Pd/C. A cost-effective solution for agomelatine intermediate manufacturing.
Novel metal-free synthesis of trifluoromethyl selenium substituted azaspiro compounds. Cost-effective, scalable process for pharmaceutical intermediates supply chain.
Patent CN111808040B reveals a green aqueous synthesis for 2-oxo-oxazolidine-4-carboxylic acids, offering high yields and cost reduction in API manufacturing.
Novel metal-free synthesis of pyrimidoindazoles via one-pot cascade. High yields, mild conditions, ideal for API intermediates and kinase inhibitor development.
Patent CN112538054B reveals a novel Pd-catalyzed carbonylation route for 1,2,4-triazole-3-ones, offering high yields and simplified supply chains for API manufacturing.
Patent CN117720537B reveals a novel indole-furan catalyst enabling high-purity asymmetric synthesis with significant cost reduction in fine chemical manufacturing and supply chain reliability.
Advanced Pd-catalyzed preparation of C-3 benzyl indolizine compounds. Enhances purity and scalability for reliable pharmaceutical intermediate supply chains.
Novel patent CN114805360B details safer temozolomide preparation avoiding toxic reagents, ensuring high purity and supply chain stability for pharmaceutical manufacturing.
Patent CN108610304A reveals a novel Pd-catalyzed route for high-purity diarylsultam compounds, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN102718659B enables high-yield synthesis of 4-bromo-2-nitrophenylacetic acid. Offers cost reduction and supply reliability for pharmaceutical intermediate manufacturing.
Patent CN114195726B reveals a novel CuCl-catalyzed route for high-purity pharmaceutical intermediates. This method offers substantial cost reduction and supply chain reliability for global buyers.
Patent CN108299296A details a visible-light induced synthesis of phenanthridine derivatives using organic photocatalysts, offering cost-effective and scalable pharmaceutical intermediate manufacturing solutions.